Mucinous carcinoma of thyroid gland. Report of a primary and a metastatic mucinous tumour from ovarian adenocarcinoma with immunohistochemical study and review of literature.
Mucinous carcinoma of the thyroid gland is an uncommon tumour that from the histological point of view, resembles mucinous carcinoma of others sites. Although a mucinous appearance has sometimes been reported in association with cases of typical thyroid carcinoma, true mucinous carcinoma is exceptionally rare. We describe two cases of thyroid tumours with mucinous differentiation studied with immunohistochemistry. Both cases disclosed a similar histological appearance, with small nests and sheets of malignant epithelial cells associated with extensive extracellular mucin that substituted and entrapped the follicular parenchyma of the thyroid. Thyroglobulin and focally thyroid transcription factor (TTF) 1 were positive in one case. From these findings, we classified this tumour as primary mucinous thyroid carcinoma. Thyroglobulin and TTF-1 were negative in tumour cells of second case; on the contrary, positivity to the carcinoembryonic antigen and CA-125 was strong and generalized. However, successfully, the patient presented ascites associated to right ovarian mass. In this case, thyroid tumour represents the first clinical sign of an ovarian mucinous adenocarcinoma, and it has not been previously described in literature. Both patients died after few months to diagnosis. In conclusion, primary and secondary mucinous carcinoma are rare and unusual tumours of the thyroid gland that can be a cause of pitfall in differential diagnosis. In these cases, for a correct diagnosis, a complete clinical history, restricted histological criteria and immunohistochemical panel are necessary.
D'Antonio
Antonio
A
Unità operativa di Anatomia Patologica, Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli, via A. Cardarelli 9, 80131 Napoli, Italy. ada66@inwind.it
Addesso
Maria
M
De Dominicis
Gianfranco
G
Boscaino
Amedeo
A
Liguori
Guiseppina
G
Nappi
Oscar
O
D002288:Adenocarcinoma, Mucinous / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology* / Q000556:secondary*; D018394:CA-125 Antigen / Q000378:metabolism; D002272:Carcinoembryonic Antigen / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008875:Middle Aged; D009687:Nuclear Proteins / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology*; D013954:Thyroglobulin / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000556:secondary*; D000074482:Thyroid Nuclear Factor 1; D014157:Transcription Factors / Q000378:metabolism
D018394:CA-125 Antigen; D002272:Carcinoembryonic Antigen; C000614412:NKX2-1 protein, human; D009687:Nuclear Proteins; D000074482:Thyroid Nuclear Factor 1; D014157:Transcription Factors; D013954:Thyroglobulin
Cancer. 1985 Dec 1;56(11):2647-50
2996743
Cancer. 1976 Sep;38(3):1323-5
182353
Pathol Res Pract. 1993 Jun;189(5):608-12; discussion 612-5
8397391
Pathol Res Pract. 1986 Aug;181(4):464-71
3020530
J Clin Pathol. 1987 Aug;40(8):890-5
3654988
Cancer. 1980 May 15;45(10):2564-7
6247054
Arch Pathol Lab Med. 2000 Oct;124(10 ):1547-52
11035596
Mayo Clin Proc. 1984 Dec;59(12):856-9
6503368
Hum Pathol. 2005 Jun;36(6):698-701
16021578
Pathology. 2006 Apr;38(2):184-6
16581665